Patent delisted for IMPAX drug ADRENACLICK
Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It […]
Patent Expiration
Patent Expiration
Patent Expiration
Patent delisted for IMPAX drug TWINJECT 0.15
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA.
Patent Expiration
Patent delisted for IMPAX drug TWINJECT 0.3
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA.
Patent Expiration
New patent expiration for Arbor Pharms drug BIDIL
Annual Drug Patent Expirations for BIDIL Bidil is a drug marketed by Arbor Pharms Llc and is included in one
New patent expiration for Arbor Pharms drug BIDIL Read Post »
Patent Expiration
Drug Patent Expirations for the Week of September 6, 2020
DEXYCU KIT (dexamethasone) Eyepoint pharms Patent: 10,022,502 Expiration: Sep 12, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of September 6, 2020 Read Post »
Patent Expiration
Patent delisted for Taiho Oncology drug LONSURF
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA.
Patent Expiration
Patent delisted for Merck Sharp drug PREVYMIS
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
Patent Expiration
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Patent Expiration
Patent delisted for Purdue Pharma drug TARGINIQ
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one
